Portfolio Company · Operating Co.
Company Snapshot
CRISPR Therapeutics is a healthcare, life sciences portfolio company held by New Enterprise Associates. Profile compiled from public sources; submit updates to extend the public record.
SectorHealthcare, Life Sciences
Parent PE firmNew Enterprise Associates
Ownership statusExited
WebsiteVisit ↗
Ownership Context
CRISPR Therapeutics is a former portfolio company of New Enterprise Associates. Public coverage of this company is grouped under its parent firm's profile.
Sources
https://www.nea.com/portfolioThis profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with CRISPR Therapeutics and does not provide investment advice.
Other portfolio companies of New Enterprise Associates
Brale
Technology, Fintech
Celcuity
Healthcare, Life Sciences
Cloudflare
Technology, Enterprise
Comprehensive Pharmacy Services
Healthcare, Digital Health
Comprehensive Pharmacy Services (CPS)
Healthcare, Digital Health
Corxel
Healthcare, Life Sciences
Coursera
Technology, Consumer
Curana Health
Healthcare, Digital Health
See the full New Enterprise Associates portfolio.